We believe that following TGFT, there are dramatic improvements in mood disorders due to the normalization of serotonin secretion from the intestines along with the normalization of the intestinal habitat and the overcoming of the zonulin-induced pressure on the central nervous system. The gene discussed is HP; the disease is mood disorder.